Abstract:Abstract Globally, lifespan continues to increase. A growing challenge is how to maintain a healthy aging population. In hematopoiesis, healthspan is limited by a decline in regenerative capacity and overproduction of myeloid cell types at the expense of lymphoid cell types. These alterations contribute to decreased immune function, poor response to vaccination and increased susceptibility to myeloid neoplasms. Methods to extend hematopoietic healthspan are unclear, in part due to our relatively poor understanding of the factors controlling aging. To address this gap in knowledge, we utilized mouse models to examine at what age did impaired regenerative capacity and myeloid-biased hematopoiesis begin to occur. We find that these phenotypes become significant by 9-12 months of age, representing middle age in mice. Through reciprocal transplantation studies of purified long-term hematopoietic stem cells (LT-HSCs) between young and middle-aged mice, we find that the middle-aged bone marrow (BM) microenvironment is sufficient to cause impaired regenerative capacity and myeloid-biased hematopoiesis from young LT-HSCs. These studies clearly implicate components of the BM microenvironment at middle age as causing hematopoietic aging. To uncover the factors altered in the middle-aged BM microenvironment that cause hematopoietic stem and progenitor cell aging, we utilized single cell RNA-Seq and ELISA analysis. Together, these identified a reduction in Insulin-Like Growth Factor-1 (IGF1) in the BM microenvironment as the top candidate regulator of hematopoietic stem and progenitor cell aging. Expression of the receptor for IGF1, IGF1R, was dynamically altered on hematopoietic stem and progenitor cell populations with aging, suggesting that these respond to altered local levels of IGF1. In vitro colony-forming unit studies demonstrate that stimulating hematopoietic stem and progenitor cells isolated from middle-aged mice with exogenous IGF-1 ligand resulted in a dose-dependent suppression of myeloid cell overproduction, rescuing the aging phenotype. Finally, direct restoration of IGF1 levels in the BM microenvironment by short-term intrafemoral injection, at middle age, suppressed myeloid cell overproduction and restored B cell production in the BM and peripheral blood. In summary, this study reveals a novel role for IGF1 in hematopoietic aging. We show that decline in local levels of IGF1 in the BM microenvironment at middle age cause hematopoietic aging. In addition, we demonstrate that short-term restoration of IGF1 at middle age can rescue hematopoietic aging. IGF1 thus represents an attractive candidate molecule to restore hematopoietic regenerative capacity and balanced lineage cell production to extend hematopoietic healthspan into older age. Disclosures No relevant conflicts of interest to declare.

IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons

IGF-1 Gene Transfer Modifies Inflammatory Environment and Gene Expression in the Caudate-Putamen of Aged Female Rat Brain

[Age-Dependent Alteration of Insulin and Ghrelin Expression in Pancreatic Islets of Intrauterine Growth-Retarded Rats].

Epigenetic Modification of Kiss1 Gene Expression in the AVPV is Essential for Female Reproductive Aging.

IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

IGF-1 Has Sexually Dimorphic, Pleiotropic, and Time-Dependent Effects on Healthspan, Pathology, and Lifespan.

Cardiac-specific Overexpression of Insulin-Like Growth Factor 1 Attenuates Aging-Associated Cardiac Diastolic Contractile Dysfunction and Protein Damage.

The Middle-Aged Bone Marrow Microenvironment Drives Hematopoietic Stem Cell Aging through Altered Production of Insulin-like Growth Factor-1 (IGF1)

Influence of Cardiac-Specific Overexpression of Insulin-Like Growth Factor 1 on Lifespan and Aging-Associated Changes in Cardiac Intracellular Ca2+ Homeostasis, Protein Damage and Apoptotic Protein Expression.

Insulin-Like Growth Factor I Prevents Cellular Aging via Activation of Mitophagy

Growth hormone, insulin-like growth factor-1 and the aging brain

The acceleration of reproductive aging in Nrg1 flox/flox ;Cyp19‐Cre female mice

Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function

Targeting IGF1R signaling for brain aging and Alzheimer’s disease

Growth hormone receptor gene disruption in mature‐adult mice improves male insulin sensitivity and extends female lifespan

The Insulin-like Growth Factor System and Aging

IGF-1 Acts through Kiss1-expressing Cells to Influence Metabolism and Reproduction

Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy.

Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP

Endothelial deficiency of insulin-like growth factor-1 receptor leads to blood-brain barrier disruption and accelerated endothelial senescence in mice, mimicking aspects of the brain aging phenotype

Hypothalamic Kisspeptin Expression in Hyperandrogenic Female Rats and Aging Rats